INDICATIONS
Repatha® is indicated:
For US healthcare professionals
Repatha® is indicated:
For US healthcare professionals
Duration: 24:16 minutes
Watch Dr. Richard Wright discuss the role of Repatha®, review the clinical efficacy and safety results from FOURIER, and how Repatha® can help real patients.
Duration: 6:08 minutes
Watch Dr. Richard Wright review the efficacy and safety results of Repatha®, including a FOURIER subanalysis of patients who suffered a myocardial infarction within 1 year prior to study enrollment.
Duration: 6:19 minutes
Watch Dr. Richard Wright discuss LDL-C lowering and initiation of Repatha®, including in patients hospitalized for ACS from the EVOPACS and EVACS clinical studies.
Duration: 22:37 minutes
Watch an expert interview, Dr. Konstantinos Koskinas and Dr. Thorsten Leucker discuss the critical role of Repatha® and initiation early after an MI in an acute setting.
Duration: 10:53 minutes
Watch Dr. Michael Davidson explore a patient case scenario featuring a hypothetical 62-year-old patient with 2 prior episodes of MI who is at risk of another MI or stroke.
Duration: 5:14 minutes
Hear Dr. Shah share her insights and experience treating myocardial infarctions (MI) in patients with atherosclerotic cardiovascular disease (ASVCD); Dr. Shah identifies patients who could benefit from Repatha® to lower LDL-C and the risk of another MI or stroke.
Duration: 1:00 minute
Hear Dr. Shah discuss the urgent action needed to treat patients within the first year following an MI to reduce the risk of another MI or stroke. In the FOURIER Study, Repatha® + statin reduced the risk of MI by 27% for patients with established CVD. HR 0.73 (95% CI, 0.65 – 0.82). Not statistically significant.
Duration: 1:00 minute
Dr. Angueira-Serrano, endocrinologist, shares how access to and affordability of Repatha® improved since it first launched and his experience with coverage and the Repatha® Co-Pay Card.
Duration: 1:00 minute
Dr. Turnbo, primary care physician, explains how he achieves treatment goals for patients who have had an MI, stroke, or other cardiovascular event, and how Repatha® can help.
Duration: 1:00 minute
Dr. Shah and Dr. Turnbo share their experience with using Repatha® as a tool to reduce their patients LDL-C below 70 mg/dL.
Duration: 0:49 Minutes
“The fact that I can do an injection myself…
is so convenient for me.”*
*Individual results may vary.
Duration: 5:03 minutes
Andy was diagnosed in his 30s, and he always struggled to get his cholesterol down to an acceptable level despite eating healthy and exercise. After being on Repatha® for not even months, his LDL-C dropped from >100 to 26 mg/dL. In the FOURIER study, established CVD patients taking Repatha® + statin lowered LDL-C by 63% at 12 weeks.*
*Individual results may vary.
Duration: 4:21 minutes
Joe’s hereditary high LDL-C levels led to heart surgery and large lifestyle changes. After Joe went on Repatha®, he was very happy to see his LDL-C level on his blood report drop from 130 to 35 mg/dL.*
*Individual results may vary.
Duration: 0:55 minutes
“The Repatha® Co-Pay Card was very useful because it made Repatha® more affordable for me.”*
*Individual results may vary.
ACS, acute coronary syndrome; ASCVD, atherosclerotic cardiovascular disease; CVD, cardiovascular disease; LDL-C, low‐density lipoprotein cholesterol; MI, myocardial infarction; PCSK9, proprotein convertase subtilisin/kexin type 9.